Covered recipient · General Payments record
FERNANDO QUEZADA
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$1,840.69
- Reported across 42 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $1,000.00 | 1 |
| Food and Beverage | $328.71 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $1,012.27 | 2 |
| Novo Nordisk AS | $64.29 | 3 |
| Lilly USA, LLC | $62.21 | 3 |
| Astellas Pharma US Inc | $61.56 | 2 |
| ABBVIE INC. | $52.63 | 2 |
| GlaxoSmithKline, LLC. | $28.40 | 1 |
| Abbott Laboratories | $24.78 | 1 |
| Exact Sciences Corporation | $22.57 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $24.78 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125303695 | CMS |
| ABBVIE INC. | $32.95 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108048703 | CMS |
| ABBVIE INC. | $19.68 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108048705 | CMS |
| Astellas Pharma US Inc | $31.96 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139515641 | CMS |
| Astellas Pharma US Inc | $29.60 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139511845 | CMS |
| AstraZeneca Pharmaceuticals LP | $1,000.00 | 04/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105845721 | CMS |
| AstraZeneca Pharmaceuticals LP | $12.27 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105866822 | CMS |
| Exact Sciences Corporation | $22.57 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114843286 | CMS |
| GlaxoSmithKline, LLC. | $28.40 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115951798 | CMS |
| Lilly USA, LLC | $26.98 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135638776 | CMS |
| Lilly USA, LLC | $21.96 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135650649 | CMS |
| Lilly USA, LLC | $13.27 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135650651 | CMS |
| Novo Nordisk Inc | $23.19 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100268894 | CMS |
| Novo Nordisk Inc | $18.94 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100259155 | CMS |
| Novo Nordisk Inc | $22.16 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100249442 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.